Bottom line Semaglutide is a GLP-1 medication available in three formulas: Ozempic, an injectable medication to treat diabetes
Safety, tolerability, manufacturing scale, reimbursement and long-term outcomes will increasingly determine which products become commercial winners
Because it supports rather than disrupts the barrier, it rarely causes the peeling and stinging associated with retinoids
These agents directly stimulate GLP-1 receptors throughout the body, producing effects that extend beyond glucose control
Insulin doesn't pass into breast milk in meaningful amounts, and metformin appears at very low levels with no adverse effects on babies
Sequence alignment results showed that the dimerization sites were not conserved between omega GSTs and CLICs (Fig